{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:56Z","timestamp":1790948396220,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta Corporate Giving","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijrobp.2025.03.046","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T01:35:04Z","timestamp":1743644104000},"page":"698-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-163X","authenticated-orcid":false,"given":"Jasmijn M.","family":"Westerhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobien C.M.","family":"Scheepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanne F.","family":"van Wolffelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe","family":"Bernchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Bahij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Christodouleas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia S.W.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios T.","family":"Colonias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Schytte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn P.W.","family":"Intven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois A.","family":"Daamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.046_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0002","unstructured":"Integraal Kankercentrum Nederland (IKNL), Dutch Pancreatic Cancer Group, LHW. Alvleesklierkanker in Nederland - kleine stappen vooruit; 2021. Available at: https:\/\/iknl.nl\/getmedia\/c019fad2-624a-4b38-865d-9222db3b836a\/Alvleesklierkanker-in-Nederland.pdf. Accessed April 15, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0003","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0004","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1245\/s10434-016-5515-6","article-title":"Impact of portal vein involvement from pancreatic cancer on metastatic pattern after surgical resection","volume":"23","author":"Mierke","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.mpa.0000166998.04266.88","article-title":"Factors predicting recurrence after resection of pancreatic ductal carcinoma","volume":"31","author":"Shibata","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0006","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","article-title":"Recurrence after resection for ductal adenocarcinoma of the pancreas","volume":"21","author":"Sperti","year":"1997","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0008","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00432-012-1165-7","article-title":"Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: Predictors and implications for adjuvant chemoradiotherapy","volume":"138","author":"Zhang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0009","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1200\/JCO.2010.30.3446","article-title":"Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: A randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study","volume":"28","author":"Van Laethem","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","article-title":"A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer","volume":"101","author":"Ueno","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0011","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","article-title":"Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial","volume":"299","author":"Regine","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0012","doi-asserted-by":"crossref","first-page":"711","DOI":"10.6004\/jnccn.2018.7013","article-title":"Clinical impact of local progression in pancreatic cancer","volume":"16","author":"Cardillo","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0013","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205917","article-title":"Variations of MRI-assessed peristaltic motions during radiation therapy","volume":"13","author":"Mostafaei","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0015","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac8ddd","article-title":"Dosimetric impact of intrafraction motion under abdominal compression during MR-guided SBRT for (Peri-) pancreatic tumors","volume":"67","author":"Grimbergen","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/joim.12516","article-title":"The development of the MRI linac system for online MRI-guided radiotherapy: A clinical update","volume":"280","author":"Lagendijk","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110064","article-title":"Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study","volume":"191","author":"Chuong","year":"2024","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ijrobp.2025.03.046_bib0018","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","volume":"8","author":"Rudra","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cancers15010007","article-title":"Stereotactic MR-guided adaptive radiotherapy for pancreatic tumors: Updated results of the montpellier prospective registry study","volume":"15","author":"Bordeau","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"4","author":"Von Elm","year":"2007","journal-title":"PLOS Med"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0021","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fonc.2020.01328","article-title":"The MOMENTUM study: An international registry for the evidence-based introduction of MR-guided adaptive therapy","volume":"10","author":"de Mol van Otterloo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0022","unstructured":"EORTC QLQ-C30 Scoring Manual The EORTC QLQ-C30. 2001. Available at: https:\/\/qol.eortc.org\/manual\/scoring-manual\/. Accessed April 15, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0023","unstructured":"Protocol Development | CTEP. Common Terminology Criteria for Adverse Events (CTCAE). Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Accessed April 19, 2022."},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0024","first-page":"54","article-title":"Adaptive radiotherapy: The Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","article-title":"Analysis and interpretation of health-related quality-of-life data from clinical trials: Basic approach of The National Cancer Institute of Canada Clinical Trials Group","volume":"41","author":"Osoba","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0026","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1040673","article-title":"Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac","volume":"13","author":"Eijkelenkamp","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0028","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0167-8140(23)08513-4","article-title":"Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial","volume":"182","author":"Chuong","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.prro.2016.05.005","article-title":"Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer","volume":"6","author":"Rao","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0031","article-title":"Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol","volume":"47","author":"Grimbergen","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0032","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2024.10.026","article-title":"NRG Oncology International Consensus Contouring Atlas on target volumes and dosing strategies for dose-escalated pancreatic cancer radiation therapy","volume":"121","author":"Sanford","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0034","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1245\/s10434-022-12742-3","article-title":"A randomized, phase II, clinical trial of preoperative fractionated radiation therapy versus stereotactic body radiation therapy for resectable, borderline resectable, or locally advanced type: A pancreatic adenocarcinoma","volume":"30","author":"Saif","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s13063-022-06829-1","article-title":"A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)","volume":"23","author":"van Goor","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0036","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1186\/s12885-022-10419-4","article-title":"Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): A nationwide multicenter randomized controlled trial according to a TwiCs design","volume":"22","author":"Doppenberg","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.046_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-022-01988-6","article-title":"MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): An open randomized, multicentric, parallel group clinical trial (MASPAC)","volume":"17","author":"Pavic","year":"2022","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625003074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625003074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:24:05Z","timestamp":1749201845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625003074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0360301625003074"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.046","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}